NYSE:ABBV - AbbVie Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $160.50
Forecasted Upside: 14.37 %
Number of Analysts: 16
Breakdown:
1 Sell Ratings
6 Hold Ratings
9 Buy Ratings
0 Strong Buy Ratings

^$140.34 As of 08/8/2022 01:00 AM ET

▲ +2.3 (1.67%)

1 month | 3 months | 12 months

Get New AbbVie Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for ABBV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ABBV

^$160.50

▲ +14.37% Upside Potential

This price target is based on 16 analysts offering 12 month price targets for AbbVie in the last 3 months. The average price target is $160.50, with a high forecast of $200.00 and a low forecast of $135.00. The average price target represents a 14.37% upside from the last price of $140.34.

Current Consensus is Buy

The current consensus among 16 contributing investment analysts is to buy stock in AbbVie. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
13 buy ratings
6 hold ratings
1 sell ratings

Ratings as of

2/14/2021

0 strong buy ratings
12 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

5/15/2021

0 strong buy ratings
10 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

8/13/2021

0 strong buy ratings
8 buy ratings
2 hold ratings
1 sell ratings

Ratings as of

11/11/2021

0 strong buy ratings
10 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

2/9/2022

0 strong buy ratings
10 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

5/10/2022

0 strong buy ratings
10 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

7/9/2022

0 strong buy ratings
9 buy ratings
6 hold ratings
1 sell ratings

Ratings as of

8/8/2022

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
8/1/2022	Morgan Stanley	Lower Price Target	Overweight	$191.00 ➝ $188.00	Low
8/1/2022	UBS Group	Lower Price Target	Neutral	$154.00 ➝ $146.00	Low
8/1/2022	Atlantic Securities	Lower Price Target	Overweight ➝ Neutral	$178.00 ➝ $162.00	Low
7/29/2022	Piper Sandler	Lower Price Target		$160.00 ➝ $155.00	Low
7/27/2022	UBS Group	Boost Price Target	Outperform	$154.00	Low
7/8/2022	Morgan Stanley	Boost Price Target	Overweight	$188.00 ➝ $191.00	N/A
5/23/2022	SVB Leerink	Initiated Coverage	Underperform	$140.00	High
5/6/2022	Daiwa Capital Markets	Downgrade	Outperform ➝ Neutral	$150.00	Low
5/2/2022	Wells Fargo & Company	Boost Price Target		$165.00 ➝ $200.00	Medium
4/25/2022	BMO Capital Markets	Boost Price Target	Outperform	$161.00 ➝ $174.00	Medium
4/12/2022	The Goldman Sachs Group	Boost Price Target	Neutral	$122.00 ➝ $140.00	High
4/12/2022	Barclays	Boost Price Target	Equal Weight	$150.00 ➝ $174.00	High
4/6/2022	Morgan Stanley	Boost Price Target	Overweight	$142.00 ➝ $192.00	Medium
3/1/2022	Citigroup	Boost Price Target		$155.00 ➝ $170.00	Low
2/28/2022	UBS Group	Downgrade	Buy ➝ Neutral	$129.00 ➝ $147.00	Low
2/4/2022	Mizuho	Boost Price Target	Buy	$154.00 ➝ $166.00	Low
2/3/2022	JPMorgan Chase & Co.	Boost Price Target		$165.00 ➝ $180.00	Low
2/3/2022	Bank of America	Boost Price Target	Neutral	$135.00 ➝ $138.00	Medium
2/3/2022	The Goldman Sachs Group	Boost Price Target	Neutral	$117.00 ➝ $122.00	Medium
2/3/2022	BMO Capital Markets	Boost Price Target	Outperform	$153.00 ➝ $154.00	Medium
2/3/2022	Barclays	Boost Price Target	Equal Weight ➝ Equal Weight	$133.00 ➝ $150.00	High
1/27/2022	Citigroup	Boost Price Target		$125.00 ➝ $155.00	Medium
1/24/2022	Morgan Stanley	Boost Price Target	Overweight	$124.00 ➝ $142.00	Medium
1/20/2022	Barclays	Boost Price Target	Equal Weight	$118.00 ➝ $133.00	High
1/18/2022	Cowen	Boost Price Target		$130.00 ➝ $150.00	High
1/13/2022	Redburn Partners	Initiated Coverage	Buy		High
1/12/2022	BMO Capital Markets	Boost Price Target	Outperform	$134.00 ➝ $153.00	Low
1/5/2022	Mizuho	Boost Price Target	Buy	$132.00 ➝ $154.00	Medium
1/3/2022	Piper Sandler	Boost Price Target		$129.00 ➝ $160.00	Low
12/17/2021	The Goldman Sachs Group	Initiated Coverage	Neutral	$113.00	High
12/8/2021	Wells Fargo & Company	Initiated Coverage	Overweight	$165.00	High
12/7/2021	BMO Capital Markets	Reiterated Rating	Buy	$134.00	Low
12/7/2021	SVB Leerink	Reiterated Rating	Buy		Low
11/24/2021	Truist Financial	Boost Price Target	Buy	$118.00 ➝ $135.00	Low
11/23/2021	Societe Generale	Upgrade	Hold ➝ Buy		High
11/1/2021	Barclays	Boost Price Target	Equal Weight	$112.00 ➝ $118.00	Low
11/1/2021	SVB Leerink	Lower Price Target	Outperform	$142.00 ➝ $135.00	Low
11/1/2021	Morgan Stanley	Boost Price Target	Overweight	$116.00 ➝ $124.00	Low
10/29/2021	Piper Sandler	Boost Price Target	Overweight	$124.00 ➝ $129.00	Low
9/2/2021	SVB Leerink	Lower Price Target	Outperform	$148.00 ➝ $142.00	Medium
8/23/2021	Cowen	Boost Price Target	Outperform	$120.00 ➝ $130.00	Low
8/20/2021	Morgan Stanley	Reiterated Rating	Buy	$116.00	Low
8/20/2021	SVB Leerink	Boost Price Target	Outperform	$145.00 ➝ $148.00	Low
8/5/2021	Argus	Boost Price Target	Buy ➝ Buy	$130.00 ➝ $140.00	Low
8/2/2021	SVB Leerink	Boost Price Target	Outperform	$144.00 ➝ $145.00	Medium
8/2/2021	Mizuho	Boost Price Target	Buy	$128.00 ➝ $131.00	Medium
8/2/2021	Barclays	Boost Price Target	Equal Weight	$105.00 ➝ $112.00	Medium
7/27/2021	Truist Financial	Initiated Coverage	Buy	$117.00	Low
7/2/2021	Daiwa Capital Markets	Initiated Coverage	Outperform		Low
5/3/2021	BMO Capital Markets	Boost Price Target	Outperform	$127.00 ➝ $129.00	High
5/3/2021	Mizuho	Boost Price Target	Buy	$126.00 ➝ $128.00	High
4/30/2021	Piper Sandler	Boost Price Target	Overweight	$120.00 ➝ $124.00	Low
4/7/2021	Royal Bank of Canada	Initiated Coverage		$135.00	Low
3/30/2021	SVB Leerink	Boost Price Target	Outperform	$140.00 ➝ $144.00	Low
2/4/2021	SVB Leerink	Boost Price Target	In-Line ➝ Outperform	$128.00 ➝ $140.00	Low
2/4/2021	Royal Bank of Canada	Boost Price Target	Outperform	$129.00 ➝ $135.00	Low
2/4/2021	Mizuho	Boost Price Target	Buy	$117.00 ➝ $126.00	Low
1/28/2021	Morgan Stanley	Lower Price Target	Overweight	$120.00 ➝ $116.00	Medium
12/16/2020	SVB Leerink	Boost Price Target	Outperform	$119.00 ➝ $128.00	Medium
12/15/2020	Mizuho	Boost Price Target		$111.00 ➝ $117.00	Medium
11/30/2020	Morgan Stanley	Boost Price Target	Positive ➝ Overweight	$108.00 ➝ $120.00	Low
11/18/2020	BMO Capital Markets	Initiated Coverage	Outperform	$123.00 ➝ $123.00	Medium
11/10/2020	Sanford C. Bernstein	Initiated Coverage	Outperform	$120.00	High
11/2/2020	SVB Leerink	Lower Price Target	Outperform	$122.00 ➝ $119.00	High
10/23/2020	Truist Financial	Initiated Coverage	Buy	$110.00	Low
10/20/2020	The Goldman Sachs Group	Downgrade	Neutral ➝ Sell		High
10/16/2020	JPMorgan Chase & Co.	Boost Price Target	Overweight	$115.00 ➝ $120.00	Low
9/29/2020	Berenberg Bank	Initiated Coverage	Hold	$98.00	Low
9/27/2020	Mizuho	Reiterated Rating	Buy	$111.00	Low
9/2/2020	Citigroup	Boost Price Target	Buy	$98.00 ➝ $105.00	Medium
8/20/2020	Morgan Stanley	Boost Price Target	Overweight	$95.00 ➝ $108.00	Medium
8/3/2020	Mizuho	Boost Price Target	Buy	$110.00 ➝ $111.00	Low
8/3/2020	Royal Bank of Canada	Boost Price Target	Outperform	$125.00 ➝ $127.00	Low
6/29/2020	Mizuho	Boost Price Target	Top Pick ➝ Buy	$101.00 ➝ $110.00	Low
6/25/2020	Royal Bank of Canada	Boost Price Target	Outperform	$102.00 ➝ $125.00	Medium
6/23/2020	Atlantic Securities	Upgrade	Neutral ➝ Overweight	$115.00	Medium
6/18/2020	Royal Bank of Canada	Reiterated Rating	Buy	$102.00	Low
6/17/2020	UBS Group	Boost Price Target		$96.00 ➝ $109.00	Low
6/10/2020	Evercore ISI	Initiated Coverage	Buy	$111.00	High
6/10/2020	Piper Sandler	Boost Price Target		$97.00 ➝ $110.00	High
6/9/2020	Wolfe Research	Upgrade	Peer Perform ➝ Outperform		Low
6/2/2020	Argus	Upgrade	Hold ➝ Buy	$91.40 ➝ $115.00	Low
5/28/2020	Royal Bank of Canada	Reiterated Rating	Buy	$102.00	Low
5/18/2020	Bank of America	Initiated Coverage	Neutral	$95.00	Low
5/12/2020	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$105.00	Medium
5/11/2020	Morgan Stanley	Reiterated Rating	Overweight	$95.00	High
5/11/2020	SVB Leerink	Boost Price Target	Outperform	$107.00 ➝ $122.00	High
5/4/2020	SVB Leerink	Boost Price Target	Outperform	$103.00 ➝ $107.00	Low
5/1/2020	Mizuho	Reiterated Rating	Buy	$100.00	Medium
4/20/2020	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$79.00 ➝ $93.00	Low
4/13/2020	UBS Group	Lower Price Target	Buy	$106.00 ➝ $96.00	Low
4/12/2020	Royal Bank of Canada	Reiterated Rating	Hold	$79.00	Low
3/23/2020	Societe Generale	Downgrade	Buy ➝ Hold		High
2/27/2020	Barclays	Initiated Coverage	Equal Weight	$97.00 ➝ $97.00	High
2/18/2020	Cowen	Boost Price Target	Outperform	$98.00 ➝ $105.00	Low
2/10/2020	Mizuho	Boost Price Target		$96.00 ➝ $104.00	High
2/7/2020	Piper Sandler	Boost Price Target	Overweight	$95.00 ➝ $97.00	Low
2/5/2020	Mizuho	Initiated Coverage	Buy	$96.00 ➝ $96.00	Low
1/23/2020	Royal Bank of Canada	Reiterated Rating	Hold	$86.00	High
1/6/2020	Royal Bank of Canada	Initiated Coverage	Sector Perform	$86.00	Low
1/3/2020	Bank of America	Downgrade	Buy ➝ Neutral		Low
12/26/2019	Cowen	Boost Price Target	Outperform	$90.00 ➝ $98.00	Low
11/20/2019	Citigroup	Boost Price Target	Buy	$90.00 ➝ $98.00	Medium
11/19/2019	UBS Group	Boost Price Target	Buy	$79.00 ➝ $96.00	High
11/1/2019	Piper Jaffray Companies	Boost Price Target		$81.00 ➝ $90.00	High
9/26/2019	Citigroup	Upgrade	Neutral ➝ Buy	$87.00 ➝ $90.00	Medium
9/24/2019	Cowen	Set Price Target	Buy	$90.00	Low
9/12/2019	UBS Group	Upgrade	Neutral ➝ Buy	$85.00 ➝ $79.00	Low
9/4/2019	Piper Jaffray Companies	Boost Price Target	Overweight	$80.00 ➝ $81.00	Medium
8/20/2019	Piper Jaffray Companies	Upgrade	Neutral ➝ Overweight	$80.00	High
7/26/2019	Piper Jaffray Companies	Set Price Target	Hold	$80.00	N/A
7/2/2019	SVB Leerink	Upgrade	Buy		Low
6/27/2019	Wolfe Research	Upgrade	Underperform ➝ Peer Perform		Medium
6/26/2019	Citigroup	Reiterated Rating	Hold		Medium
6/26/2019	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$88.00	High
5/28/2019	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral	$84.00	High
4/28/2019	BMO Capital Markets	Upgrade	Underperform ➝ Market Perform	$71.00 ➝ $79.00	Low
4/26/2019	Credit Suisse Group	Set Price Target	Sell	$78.00	Low
3/25/2019	Argus	Downgrade	Buy ➝ Hold		Low
2/14/2019	Barclays	Reiterated Rating	Hold	$86.00	Low
1/25/2019	Credit Suisse Group	Set Price Target	Hold	$79.00	High
1/23/2019	UBS Group	Reiterated Rating	Neutral ➝ Neutral	$97.00 ➝ $91.00	Low
1/17/2019	Credit Suisse Group	Upgrade	Hold	$79.00	Medium
1/3/2019	Bank of America	Downgrade	Buy ➝ Neutral		Medium
12/26/2018	Standpoint Research	Initiated Coverage	Buy ➝ Buy		High
12/20/2018	Morgan Stanley	Set Price Target	Hold	$88.00	High
11/6/2018	Argus	Lower Price Target	Buy ➝ Buy	$130.00 ➝ $115.00	Low
11/5/2018	BMO Capital Markets	Lower Price Target	Underperform ➝ Underperform	$78.00 ➝ $71.00	Low
11/4/2018	Barclays	Reiterated Rating	Hold	$90.00	High
11/2/2018	Credit Suisse Group	Set Price Target	Hold	$85.00	High
10/23/2018	Wolfe Research	Initiated Coverage	Underperform		Low
10/22/2018	SunTrust Banks	Lower Price Target	Buy ➝ Buy	$157.00 ➝ $135.00	High
10/20/2018	Credit Suisse Group	Set Price Target	Sell	$85.00	High
10/14/2018	Credit Suisse Group	Set Price Target	Hold	$85.00	Medium
10/4/2018	Bank of America	Lower Price Target	Buy ➝ Buy	$107.00 ➝ $106.00	Medium
8/22/2018	Bank of America	Boost Price Target	Buy ➝ Buy	$105.00 ➝ $107.00	Low
8/22/2018	BMO Capital Markets	Reiterated Rating	Sell	$78.00	Low
7/30/2018	Bank of America	Lower Price Target	Buy ➝ Buy	$112.00 ➝ $105.00	Medium
7/27/2018	Piper Jaffray Companies	Reiterated Rating	Hold	$100.00	Low
7/27/2018	Cowen	Set Price Target	Buy	$110.00	Low
7/27/2018	BMO Capital Markets	Reiterated Rating	Sell	$78.00	Low
7/15/2018	Jefferies Financial Group	Set Price Target	Buy	$100.00	Low
7/13/2018	Credit Suisse Group	Upgrade	Hold	$89.00	Low
7/12/2018	Berenberg Bank	Initiated Coverage	Hold	$105.00	Low
6/11/2018	Argus	Lower Price Target	Buy ➝ Buy	$145.00 ➝ $130.00	Low
6/6/2018	Credit Suisse Group	Set Price Target	Sell	$89.00	Low
6/1/2018	Piper Jaffray Companies	Downgrade	Overweight ➝ Neutral	$125.86 ➝ $66.62	Low
5/30/2018	Deutsche Bank Aktiengesellschaft	Downgrade	Neutral ➝ Underperform	$125.86 ➝ $65.61	Medium
5/30/2018	Deutsche Bank Aktiengesellschaft	Downgrade	Neutral ➝ Underperform	$125.86 ➝ $65.61	Low
5/29/2018	Credit Suisse Group	Downgrade	Neutral ➝ Sell	$104.00 ➝ $89.00	Medium
5/24/2018	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		High
5/23/2018	BMO Capital Markets	Lower Price Target	Underperform ➝ Underperform	$81.00 ➝ $78.00	Low
5/1/2018	BMO Capital Markets	Reiterated Rating	Sell	$81.00	Low
4/30/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$131.00 ➝ $110.00	High
4/27/2018	Credit Suisse Group	Lower Price Target	Neutral ➝ Neutral	$109.00 ➝ $104.00	Medium
4/22/2018	Credit Suisse Group	Set Price Target	Hold	$109.00	Low
4/13/2018	Jefferies Financial Group	Set Price Target	Buy	$122.00	Low
4/10/2018	Credit Suisse Group	Set Price Target	Hold	$109.00	Low
4/5/2018	Barclays	Lower Price Target	Equal Weight ➝ Equal Weight	$120.00 ➝ $102.00	Low
4/5/2018	BMO Capital Markets	Reiterated Rating	Sell	$80.00	Low
3/26/2018	Bank of America	Set Price Target	Hold	$120.00	High
3/23/2018	Jefferies Financial Group	Set Price Target	Buy	$125.00	High
3/23/2018	Credit Suisse Group	Lower Price Target	Neutral	$109.00 ➝ $98.10	Medium
3/23/2018	BMO Capital Markets	Lower Price Target	Underperform ➝ Underperform	$95.00 ➝ $80.00	Medium
3/22/2018	BMO Capital Markets	Set Price Target	Sell	$95.00	High
3/13/2018	BMO Capital Markets	Set Price Target	Sell	$95.00	Low
2/26/2018	Jefferies Financial Group	Set Price Target	Buy	$145.00	Low
2/21/2018	BMO Capital Markets	Set Price Target	Sell	$95.00	Low
2/15/2018	BMO Capital Markets	Reiterated Rating	Sell	$95.00	High
2/15/2018	Piper Jaffray Companies	Boost Price Target	Overweight	$130.00 ➝ $138.00	High
2/2/2018	Argus	Boost Price Target	Buy	$120.00 ➝ $145.00	Low
1/30/2018	Morgan Stanley	Boost Price Target	Equal Weight ➝ Equal Weight	$99.00 ➝ $131.00	Low
1/29/2018	Evercore ISI	Reiterated Rating	Buy	$144.00	Low
1/29/2018	Credit Suisse Group	Set Price Target	Hold	$98.00 ➝ $135.00	Medium
1/29/2018	BMO Capital Markets	Downgrade	Market Perform ➝ Underperform	$125.86 ➝ $84.00	Low
1/29/2018	SunTrust Banks	Boost Price Target	Buy ➝ Average	$157.00	Low
1/29/2018	SVB Leerink	Downgrade	Outperform ➝ Market Perform	$127.00	Medium
1/26/2018	Piper Jaffray Companies	Boost Price Target	Outperform	$115.00 ➝ $130.00	Low
1/22/2018	Credit Suisse Group	Set Price Target	Hold	$98.00	Low
1/11/2018	BMO Capital Markets	Set Price Target	Hold	$84.00	Low
1/4/2018	Jefferies Financial Group	Boost Price Target	Buy	$115.00 ➝ $120.00	Low
1/2/2018	Piper Jaffray Companies	Reiterated Rating	Buy		High
12/20/2017	BMO Capital Markets	Set Price Target	Hold	$84.00	Medium
12/5/2017	SVB Leerink	Set Price Target	Buy	$106.00	Low
12/4/2017	BMO Capital Markets	Set Price Target	Hold	$84.00	Low
11/21/2017	BMO Capital Markets	Reiterated Rating	Hold	$84.00	N/A
11/21/2017	Societe Generale	Boost Price Target			N/A
10/30/2017	SunTrust Banks	Reiterated Rating	Buy		N/A
10/30/2017	SVB Leerink	Lower Price Target	Outperform	$108.00 ➝ $107.00	N/A
10/27/2017	BMO Capital Markets	Set Price Target	Hold	$66.00	N/A
10/27/2017	Piper Jaffray Companies	Boost Price Target	Overweight	$115.00	N/A
10/16/2017	Jefferies Financial Group	Boost Price Target	Buy	$107.00 ➝ $115.00	N/A
10/13/2017	Barclays	Boost Price Target	Equal Weight	$90.00	N/A
10/13/2017	UBS Group	Reiterated Rating	Neutral		N/A
10/11/2017	Cowen	Upgrade	Market Perform ➝ Outperform	$91.17 ➝ $105.00	N/A
10/2/2017	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$89.00 ➝ $106.00	Medium
10/1/2017	Credit Suisse Group	Reiterated Rating	Neutral	$74.00 ➝ $94.00	Medium
9/30/2017	Evercore ISI	Reiterated Rating	Outperform	$95.00 ➝ $100.00	Medium
9/29/2017	Argus	Boost Price Target	Buy	$90.00 ➝ $110.00	Low
9/29/2017	Morgan Stanley	Boost Price Target	Equal Weight	$70.00 ➝ $95.00	Low
9/28/2017	Barclays	Reiterated Rating	Hold	$68.00	Low
9/28/2017	BMO Capital Markets	Reiterated Rating	Hold	$66.00	Low
9/28/2017	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$88.00	Low
9/28/2017	Jefferies Financial Group	Reiterated Rating	Buy	$107.00	Medium
9/25/2017	UBS Group	Downgrade	Buy ➝ Neutral	$79.00 ➝ $92.00	Low
9/15/2017	Jefferies Financial Group	Reiterated Rating	Buy ➝ Buy	$94.00 ➝ $107.00	High
9/15/2017	Piper Jaffray Companies	Reiterated Rating	Buy	$100.00	High
9/13/2017	SunTrust Banks	Reiterated Rating	Buy	$95.00	Low
9/12/2017	SVB Leerink	Reiterated Rating	Market Perform		Low
9/11/2017	Cowen	Reiterated Rating	Market Perform ➝ Hold	$70.00 ➝ $95.00	Medium
9/8/2017	The Goldman Sachs Group	Reiterated Rating	Buy	$85.00 ➝ $100.00	Low
9/8/2017	Jefferies Financial Group	Reiterated Rating	Buy	$94.00	Low
8/16/2017	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$95.00	Medium

(Data available from 8/9/2017 forward)

News Sentiment Rating

0.47 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

19 very positive mentions
47 positive mentions
4 negative mentions
5 very negative mentions

Mentions as of

1/10/2022

28 very positive mentions
62 positive mentions
6 negative mentions
1 very negative mentions

Mentions as of

2/9/2022

16 very positive mentions
65 positive mentions
5 negative mentions
8 very negative mentions

Mentions as of

3/11/2022

14 very positive mentions
35 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

4/10/2022

17 very positive mentions
51 positive mentions
10 negative mentions
1 very negative mentions

Mentions as of

5/10/2022

15 very positive mentions
35 positive mentions
6 negative mentions
5 very negative mentions

Mentions as of

6/9/2022

24 very positive mentions
17 positive mentions
5 negative mentions
0 very negative mentions

Mentions as of

7/9/2022

29 very positive mentions
70 positive mentions
8 negative mentions
0 very negative mentions

Mentions as of

8/8/2022

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Today's Range

Now: $140.34

$137.77

$140.80

50 Day Range

MA: $147.32

$137.62

$154.14

52 Week Range

Now: $140.34

$105.56

$175.91

Volume

4,626,296 shs

Average Volume

6,117,487 shs

Market Capitalization

$248.14 billion

P/E Ratio

19.88

Dividend Yield

4.09%

Beta

0.7

Frequently Asked Questions

What sell-side analysts currently cover shares of AbbVie?: The following sell-side analysts have issued research reports on AbbVie in the last year: Atlantic Securities, Bank of America Co., Barclays PLC, BMO Capital Markets, Citigroup Inc., Cowen Inc, Daiwa Capital Markets, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Piper Sandler, Redburn Partners, Societe Generale, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for ABBV.
What is the current price target for AbbVie?: 16 Wall Street analysts have set twelve-month price targets for AbbVie in the last year. Their average twelve-month price target is $160.50, suggesting a possible upside of 14.4%. Wells Fargo & Company has the highest price target set, predicting ABBV will reach $200.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $135.00 for AbbVie in the next year.
View the latest price targets for ABBV.
What is the current consensus analyst rating for AbbVie?: AbbVie currently has 1 sell rating, 6 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ABBV will outperform the market and that investors should add to their positions of AbbVie.
View the latest ratings for ABBV.
What other companies compete with AbbVie?: Other companies that are similar to AbbVie include Merck & Co., Inc., Pfizer, Eli Lilly and, Bristol-Myers Squibb and Zoetis. Learn More about companies similar to AbbVie.
How do I contact AbbVie's investor relations team?: AbbVie's physical mailing address is 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL, 60064. The company's listed phone number is (847) 932-7900. The official website for AbbVie is www.abbvie.com. Learn More about contacing AbbVie investor relations.

NYSE:ABBV - AbbVie Stock Price Target and Predictions

Analyst Price Target for ABBV

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.47 (Hold)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of AbbVie?

What is the current price target for AbbVie?

What is the current consensus analyst rating for AbbVie?

What other companies compete with AbbVie?

How do I contact AbbVie's investor relations team?